Henry Adewoye

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study

Miguel Martín, Henri Roché, Tamás Pintér et al. · The Lancet Oncology · 2011 · 75 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Erythrocyte and plasma magnesium in sickle-cell anaemia.

A O Olukoga, Henry Adewoye, Rajiv T. Erasmus et al. · PubMed · 1990 · 30 citations

Anemia, Immunohematology, Electrolyte Disorder +14

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Ignace Vergote, Russell J. Schilder, Charles H. Pippitt et al. · Gynecologic Oncology · 2014 · 21 citations · Full text

Phase 1B, Pegylated Liposomal Doxorubicin, Medicine +8

Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability

Jacqueline C. Barrientos, Nina D. Wagner‐Johnston, Sven de Vos et al. · Blood · 2013 · 13 citations

Urinary Magnesium Excretion in Steady-State Sickle Cell Anaemia

A O Olukoga, Henry Adewoye, Rajiv T. Erasmus et al. · Acta Haematologica · 1993 · 11 citations

Electrolyte Disorder, Urology, Urinary Magnesium Excretion +11